| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 2,258,219 | 2,011,503 | 1,979,078 | | Cost of Revenue | 1,897,380 | 1,761,111 | 1,683,339 | | | Gross Profit | 360,839 | 250,392 | 295,739 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 156,000 | 157,405 | 152,266 | | Non Recurring | 377 | (608) | 29,773 | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 204,462 | 93,595 | 113,700 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,854 | 10,336 | 5,021 | | Earnings Before Interest And Taxes | 207,316 | 103,931 | 118,721 | | Interest Expense | 97,984 | 101,885 | 105,635 | | Income Before Tax | 109,332 | 2,046 | 13,086 | | Income Tax Expense | (22,020) | (5,499) | 16,062 | | Minority Interest | (679) | (368) | (653) | | | | Net Income From Continuing Ops | 132,151 | 9,006 | (2,615) | | | Non-recurring Events | | Discontinued Operations | 407 | 7,855 | (18,730) | | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| (252) | | Other Items |
-
|
-
|
-
| | | | Net Income | 132,558 | 16,861 | (21,597) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $132,558 | $16,861 | ($21,597) |
|
0.17% Nasdaq 
Income Statement
